期刊文献+

马传染性贫血病毒弱毒疫苗株与亲本强毒株的体内病毒载量与诱导保护性免疫关系的研究 被引量:1

Study of the Correlation between the Plasma Viral Load and Protective Immunity Induced by the Equine Infectious Anemia Attenuated Vaccine and Its Parental Virulent Strain
原文传递
导出
摘要 慢病毒免疫应答的载量阈值学说认为病毒载量决定了机体对病毒反应的类型。为了探讨马传染性贫血病毒(EIAV)血浆病毒载量与马体免疫保护的相关性,本研究利用Real-time RT-PCR方法对EIAV弱毒疫苗株(EIA-VDLV125)免疫马和EIAV强毒株(EIAVLN40)非致死剂量接种马血浆中病毒载量进行了动态比较。结果显示两组马在监测过程中皆可检测到相似水平的病毒载量(103~105copies/mL),且两者之间差异不显著(P>0.05)。以上毒株接种23周后,对马匹进行了强毒株(EIAVLN40)的致死剂量攻毒,根据攻毒后典型马传贫急性发病与否确定接种保护率。结果显示,疫苗组的保护率为67%而非致死剂量强毒组的保护率为0。以上结果提示,病毒血浆载量不是决定EIAV弱毒疫苗诱导免疫保护能力的主要或单一因素。 The threshold hypothesis of attenuated lentiviral vaccine considers that the type of host response to infections of lentiviruses depends on the viral load. To evaluate the correlation between viral loads of the attenuated vaccine strain of equine infectious anemia virus (EIAV) and their effects to induce protective immunity,longitudinal plasma viral loads in groups of horses inoculated with either an attenuated EIAV vaccine strain (EIAVDLV125) or sub-lethal dose of an EIAV virulent strain (EIAVLN40) were compared. Similar levels of plasma viral loads ranging from 10^3-10^5 copies/mL were detected from samples of these two groups of animals(P〉0.05) during 23 weeks post the inoculation. However,different responses to the challenge performed thereafter with lethal dose of the EIAV virulent strain were observed from the groups of horses inoculated with either EIAVDLV125 or sub-lethal dose of EIAVLN40. The protective efficiency was 67% (3 of 4 cases) and 0 (none of 2 cases),respectively. Our results implicate that the viral load of EIAV attenuated vaccine is not the primary factor,or at least not the solo primary factor,to determine the establishment of immune protection.
出处 《病毒学报》 CAS CSCD 北大核心 2010年第2期128-133,共6页 Chinese Journal of Virology
基金 十一五重大传染病专项(2008ZX1001-1010) 国家自然科学基金面上项目(30771994) 国家自然科学青年基金项目(30901349)
关键词 马传染性贫血病毒 弱毒疫苗 免疫保护 病毒载量 equine infectious anemia virus attenuated vaccine immune protection viral load
  • 相关文献

参考文献11

二级参考文献42

  • 1Lichtenstein D L, Issel C J, Montelaro R C, et al. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia[J]. J Virol. 1996, 6:3346-3354.
  • 2Christine M, Rousseau B, Birditt A, et al. Large-scale amplification , cloning and sequencing of near full-length HIV-1 subtype C genomes[J]. J Virol methods, 2006, 136:118-125.
  • 3Chungwon Chung, Robert H M, McGuire T C. CTL from EIAV carrier horses with diverse MHC class Ⅰ alleles recognize epitope clusters in Gag matrix and capisid proteins[J]. Virology, 2004,327 : 144-154.
  • 4Yong Hui Zheng, Hiroshi Sentsui , Yuji Kono, et al Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macropha ges[J]. Virus Res, 2000,68:93-98.
  • 5Wendy Maury, Robert J T, Quentin J, et al. Evolution of the Equine Infectious Anemia Virus Long Terminal Repeat during the Alteration of Cell Tropism [J]. J Virol, 2005, 9:5653-5664.
  • 6Payne S L, La Celle K, Pei X F, et al. Long terminal re peat sequences of equine infectious anemia virus are a ma jor determinant of cell tropism. J Gen Virol, 1999, 80 : 755-759.
  • 7Ball J M, Swaggerty C L, Pei X, et al. SU proteins from virulent and avirulent EIAV demonstrate distinct biological properties[J]. Virology. 2005, 333: 132-144.
  • 8Michael B, Prasith B, Oaks J L, et al, Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony [J]. Virology, 2001, 279 : 185-200.
  • 9Baccam P, Thompson R J, Li Y, et al. Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype[J]. J Virol, 2003, 22: 12122-12131.
  • 10Chun T W,Carruth L , Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV- 1 infection[J]. Nature, 1997, 71:7498-7508.

共引文献17

同被引文献7

  • 1Cheevers W P. Equine infectious anemia virus: immunopatho- genesis and persistence [J). Rev Infect Dis, 1985, 7(1): 83-88.
  • 2Li Feng, Leroux C, Craigo J K, et al. The S2 gene of equine in- fectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies [J], J Virol, 2000, 74(1): 573-579.
  • 3Li Feng, Puffer B A, Montelaro R C. The S2 gene of equine in- fectious anemia virus is dispensable for viral replication in vitro [J]. J Virol, 1998, 72(10): 8344-8348.
  • 4高旭.s2基因变异在中国马传染性贫血病毒弱毒疫苗致弱中作用的研究[A].北京:中国农业科学院,2009.
  • 5Ma Jian, Jiang Cenggang, Lin Yuezhi, et al. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safely of an atten- uated equine infectious anemia virus (EIAV) vaccine [J]. Arch Virol, 2009, 154(5): 867-873.
  • 6王雪峰,姜成刚,郭巍,项伟,吕晓玲,赵立平,王凤龙,孔宪刚,张晓燕,邵一鸣,周建华.马传染性贫血病毒白细胞弱毒疫苗株及其亲本毒驴强毒株前病毒基因组比较分析[J].病毒学报,2008,24(6):443-450. 被引量:5
  • 7沈荣显,相文华.马传染性贫血病驴白细胞弱毒株的致弱及免疫机理的研究[J].中国兽医学报,2003,23(5):505-512. 被引量:11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部